drugset / Trial / NCT00283777

Chromium and Insulin Action

NCT00283777

Phase 4 Completed 30 enrolled Pennington Biomedical Research Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The effect of Chromium to improve glucose levels in diabetes is controversial. The hypothesis of the study was to evaluate the effect of supplementing the diet of individuals with Type 2 diabetes with chromium picolinate and assessing the effect on blood glucose levels and insulin sensitivity

Timeline

Start
1998-08
Primary completion
2003-01
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Chromium Picolinate Other / unclassified